Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy... Show more
Industry PackagedSoftware
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CHI | 10.01 | 0.09 | +0.91% |
| Calamos Convertible Opportunities and Income Fund | |||
| RTH | 224.93 | 0.77 | +0.34% |
| VanEck Retail ETF | |||
| SMAY | 23.24 | -0.02 | -0.07% |
| FT Vest US Sm Cp Mod Buffr ETF- May | |||
| FPRO | 22.14 | -0.05 | -0.22% |
| Fidelity Real Estate Investment ETF | |||
| RWL | 96.34 | -0.23 | -0.24% |
| Invesco S&P 500 Revenue ETF | |||
A.I.dvisor tells us that DGNOF and KNAMF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DGNOF and KNAMF's prices will move in lockstep.
| Ticker / NAME | Correlation To DGNOF | 1D Price Change % | ||
|---|---|---|---|---|
| DGNOF | 100% | +2.68% | ||
| KNAMF - DGNOF | 27% Poorly correlated | N/A | ||
| NEXOY - DGNOF | 23% Poorly correlated | -1.84% | ||
| NEXOF - DGNOF | 20% Poorly correlated | N/A | ||
| EBYH - DGNOF | 10% Poorly correlated | N/A | ||
| LFMD - DGNOF | 6% Poorly correlated | +0.50% | ||
More | ||||